Edit |   |
---|---|
Product Name | Ibrutinib |
Description | An irreversible inhibitor of BTK (IC50 = 0.5 nM) that selectively blocks B cell activation, promoting apoptosis and preventing homing to the protective tumor microenvironment, at concentrations that do not affect T cell receptor signaling (1,000-fold more potent); studied clinically for the treatment of diseases associated with B cell antigen receptor signaling, including MCL, CLL, and non-Hodgkin |
Size | 50 mg |
Concentration | n/a |
Applications | n/a |
Other Names | Imbruvica|PCI 32765 |
Gene, Accession, CAS # | CAS: 936563-96-1 |
Catalog # | 16274-50 |
Price | $793.00 |
Order / More Info | Ibrutinib from CAYMAN CHEMICAL COMPANY |
Product Specific References | n/a |